|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kinjo T, Taniguchi H, Kushima R, Sekine S,
Oda I, Saka M, Gotoda T, Kinjo F, Fujita J and Shimoda T:
Histologic and immunohistochemical analyses of
alpha-fetoprotein-producing cancer of the stomach. Am J Surg
Pathol. 36:56–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inoue M, Sano T, Kuchiba A, Taniguchi H,
Fukagawa T and Katai H: Long-term results of gastrectomy for
alpha-fetoprotein-producing gastric cancer. Br J Surg.
97:1056–1061. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long
Z, Zhu H and Wang Y: Clinicopathologic features and prognostic
factors in alpha-fetoprotein-producing gastric cancers: Analysis of
104 cases. J Surg Oncol. 102:249–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Sheng W and Wang Y: An analysis of
clinicopathological features and prognosis by comparing hepatoid
adenocarcinoma of the stomach with AFP-producing gastric cancer. J
Surg Oncol. 106:299–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun W, Liu B, Chen J, Gong P, Wu X, Zhou
Liu C, Hong B and Gong W: Novel characteristics of
alpha-fetoprotein (AFP)-producing gastric cancer. Oncotarget.
8:101944–101951. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Babali A, Cakal E, Purnak T, Biyikoglu I,
Cakal B, Yüksel O and Köklü S: Serum α-fetoprotein levels in liver
steatosis. Hepatol Int. 3:551–555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Qu H, Jian M, Sun G and He Q: High
level of serum AFP is an independent negative prognostic factor in
gastric cancer. Int J Biol Markers. 30:e387–e393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng F, Sun L, Liu Z, Liu S, Zheng G, Xu
G, Guo M, Lian X, Fan D and Zhang H: Prognostic values of normal
preoperative serum cancer markers for gastric cancer. Oncotarget.
7:58459–58469. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amemiya H, Kono K, Mori Y, Takahashi A,
Ichihara F, Iizuka H, Sekikawa T and Matsumoto Y: High frequency of
c-Met expression in gastric cancers producing alpha-fetoprotein.
Oncology. 59:145–151. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guinney J, Dienstmann R, Wang X, de
Reynies A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda
G, Angelino P, et al: The consensus molecular subtypes of
colorectal cancer. Nat Med. 21:1350–1356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bradley CA, Salto-Tellez M, Laurent-Puig
P, Bardelli A, Rolfo C, Tabernero J, Khawaja HA, Lawler M, Johnston
PG and Van Schaeybroeck S; MErCuRIC consortium, : Targeting c-MET
in gastrointestinal tumours: Rationale, opportunities and
challenges. Nat Rev Clin Oncol. 14:562–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin L, Huang H and Liao W, Ma H, Liu J,
Wang L, Huang N, Liao Y and Liao W: MACC1 supports human gastric
cancer growth under metabolic stress by enhancing the Warburg
effect. Oncogene. 34:2700–2710. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong G, Wang M, Gu G, Li S, Sun X, Li Z,
Cai H and Zhu Z: MACC1 and HGF are associated with survival in
patients with gastric cancer. Oncol Lett. 15:3207–3213.
2018.PubMed/NCBI
|
|
16
|
Guo T, Yang J, Yao J, Zhang Y, Da M and
Duan Y: Expression of MACC1 and c-Met in human gastric cancer and
its clinical significance. Cancer Cell Int. 13:1212013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis-associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weidle UH, Birzele F and Krüger A:
Molecular targets and pathways involved in liver metastasis of
colorectal cancer. Clin Exp Metastasis. 32:623–635. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z,
Li M, Li J and Song L: MACC1 as a prognostic biomarker for
early-stage and AFP-normal hepatocellular carcinoma. PLoS One.
8:e642352013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie QP, Xiang C, Wang G, Lei KF and Wang
Y: MACC1 upregulation promotes gastric cancer tumor cell metastasis
and predicts a poor prognosis. J Zhejiang Univ Sci B. 17:361–366.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Y, Zhou K, Zhao W, Han R, Huo X, Yang
F and Chen J: Clinicopathological and prognostic significance of
metastasis-associated in colon cancer-1 in gastric cancer: A
meta-analysis. Int J Biol Markers. 34:27–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kataoka H, Miura Y, Joh T, Seno K, Tada T,
Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T and Itoh M:
Alpha-fetoprotein producing gastric cancer lacks transcription
factor ATBF1. Oncogene. 20:869–873. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu D, Li B, Yan B, Liu L, Jia Y, Wang Y,
Ma X and Yang F: The clinicopathological features and prognosis of
serum AFP positive gastric cancer: A report of 16 cases. Int J Clin
Exp Pathol. 13:2439–2446. 2020.PubMed/NCBI
|
|
25
|
Wang R, Li J, Xu D, Li R and Gong P:
Dynamic change in serum alpha-fetoprotein level predicts treatment
response and prognosis of alpha-fetoprotein-producing gastric
cancer. Medicine (Baltimore). 99:e233262020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen D, Lin X, Zhang C, An G, Li Z, Dong
B, Shen L, Gao J and Zhang X: Activated Wnt signaling promotes
growth and progression of AFP-producing gastric cancer in
preclinical models. Cancer Manag Res. 11:1349–1362. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin L, Liu Y, Pan C, Zhang J, Zhao Y, Shao
R, Huang Z, Su Y, Shi M, Bin J, et al: Gastric cancer cells escape
metabolic stress via the DLC3/MACC1 axis. Theranostics.
9:2100–2114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang TJ, Wang JY, Lin SR, Lian ST and
Hsieh JS: Overexpression of the c-met protooncogene in human
gastric carcinoma-correlation to clinical features. Acta Oncol.
40:638–643. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Janjigian YY, Tang LH, Coit DG, Kelsen DP,
Francone TD, Weiser MR, Jhanwar SC and Shah MA: MET expression and
amplification in patients with localized gastric cancer. Cancer
Epidemiol Biomarkers Prev. 20:1021–1027. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee HE, Kim MA, Lee HS, Jung EJ, Yang HK,
Lee BL, Bang YJ and Kim WH: MET in gastric carcinomas: Comparison
between protein expression and gene copy number and impact on
clinical outcome. Br J Cancer. 107:325–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakajima M, Sawada H, Yamada Y, Watanabe
A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T and
Nakano H: The prognostic significance of amplification and
overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Cancer. 85:1894–1902. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiang Y, Liang B, Jiang Y, Sun F, Zhao Y,
Wu Q, Hu X, Liu Y, Huang Q, Liao W, et al: MET transcriptional
regulator/serine peptidase inhibitor kunitz type 1 panel operating
through HGF/c-MET axis as a prognostic signature in pan-cancer.
Cancer Med. 10:2442–2460. 2021. View Article : Google Scholar : PubMed/NCBI
|
